Lataa...
Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial
BACKGROUND: The role of trimethylamine-N-oxide (TMAO) in type 2 diabetes (T2D) is currently partially understood and controversial. OBJECTIVE: The aim of this study was to investigate associations between TMAO and related metabolites with T2D risk in subjects at high risk of cardiovascular disease....
Tallennettuna:
| Julkaisussa: | Am J Clin Nutr |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862602/ https://ncbi.nlm.nih.gov/pubmed/29982310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajcn/nqy058 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|